Edition:
United States

Karolinska Development AB (KDEV.ST)

KDEV.ST on Stockholm Stock Exchange

4.95SEK
24 Aug 2017
Change (% chg)

0.00kr (+0.00%)
Prev Close
4.95kr
Open
4.95kr
Day's High
4.98kr
Day's Low
4.95kr
Volume
6,001
Avg. Vol
21,524
52-wk High
7.50kr
52-wk Low
4.70kr

KDEV.ST

Chart for KDEV.ST

About

Karolinska Development AB is a Sweden-based investment company. The Company provides capital to biotechnology firms, as well as develops and commercializes biotechnological products. Its activities are involved in a range of areas: oncology, infections and wound healing, women’s health, cardiovascular and hematology, medical... (more)

Overall

Beta: 1.20
Market Cap(Mil.): kr311.15
Shares Outstanding(Mil.): 62.86
Dividend: --
Yield (%): --

Financials

  KDEV.ST Industry Sector
P/E (TTM): -- 30.06 32.82
EPS (TTM): -2.67 -- --
ROI: -30.59 13.89 14.97
ROE: -134.48 16.70 16.21

BRIEF-Karolinska Development Q1 net loss narrow to SEK 25.2 mln

* SAID ON TUESDAY Q1 REVENUE WAS SEK 0.6 MLN VS SEK 0.6 MLN YR AGO

May 17 2017

BRIEF-Karolinska Development announces outcome of set-off issue

* REG-KAROLINSKA DEVELOPMENT ANNOUNCES OUTCOME OF SET-OFF ISSUE

Apr 05 2017

BRIEF-Karolinska Development: research collaboration with Memorial Sloan Kettering Cancer Center

* Karolinska Development company Aprea Therapeutics announces research collaboration with Memorial Sloan Kettering Cancer Center

Mar 22 2017

Earnings vs. Estimates